Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service.
David G KielyNeil HamiltonSteven WoodCharlotte DurringtonFernando ExpostoRuvimbo MuzwidzwaLouise RaiteriAmélie BeaudetAudrey MullerRafael SauterNadia PillaiAllan Lawrienull nullPublished in: BMJ open (2024)
Findings from this study support that risk assessment at diagnosis is prognostic for mortality in patients with CTEPH. Low-risk patients have better survival and HRQoL and lower HCRU and costs compared with intermediate-risk and high-risk patients.
Keyphrases
- pulmonary hypertension
- risk assessment
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- healthcare
- mental health
- primary care
- pulmonary arterial hypertension
- heavy metals
- cardiovascular disease
- coronary artery disease
- adipose tissue
- risk factors
- human health
- climate change
- coronary artery
- weight loss
- drug induced